Arylsulfonamido-substituted hydroxamic acids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142378, 514311, 514331, 514332, 514341, 514365, 514396, 514406, 514432, 514445, 514451, 514602, 514604, 544168, 546175, 546247, 546265, 546276, 546336, 546337, 548205, 5483351, 5483381, 549 13, 549 65, 549426, 564 84, 564 90, 564 92, 564 94, C07D21342, A61K 3144

Patent

active

054552583

ABSTRACT:
Particularly the invention relates to the compounds of formula I ##STR1## (a) wherein Ar is carbocyclic or heterocyclic aryl;
R is hydrogen, lower alkyl, carbocyclic aryl-lower alkyl, carbocyclic aryl, heterocyclic aryl, biaryl, biaryl-lower alkyl, heterocyclic aryl-lower alkyl, mono- or poly-halo-lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, C.sub.3 -C.sub.7 -cycloalkyl-lower alkyl, hydroxy-lower alkyl, acyloxy-lower alkyl, lower alkoxy-lower alkyl, lower alkyl-(thio, sulfinyl or sulfonyl)-lower alkyl, amino, mono- or di-lower alkylamino)-lower alkyl, acylamino-lower alkyl, (N-lower alkyl-piperazino or N-aryl-lower alkylpiperazino)-lower alkyl, or (morpholino, thiomorpholino, piperidino, pyrrolidino, piperidyl or N-lower alkylpiperidyl)-lower alkyl;
R.sub.1 is hydrogen, lower alkyl, carbocyclic aryl-lower alkyl, carbocyclic aryl, heterocyclic aryl, biaryl, biaryl-lower alkyl, heterocyclic aryl-lower alkyl, mono- or poly-halo-lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, C.sub.3 -C.sub.7 -cycloalkyl-lower alkyl, hydroxy-lower alkyl, acyloxy-lower alkyl, lower alkoxy-lower alkyl, (carbocyclic or heterocyclic aryl)-lower alkoxy-lower alkyl, lower alkyl-(thio, sulfinyl or sulfonyl)-lower alkyl, (amino, mono- or di-lower alkylamino)-lower alkyl, (N-lower alkyl-piperazino or N-aryl-lower alkylpiperazino)-lower alkyl, (morpholino, thiomorpholino, piperidino, pyrrolidino, piperidyl or N-lower alkylpiperidyl)-lower alkyl, acylamino-lower alkyl, piperidyl or N-lower alkylpiperidyl;
R.sub.2 is hydrogen or lower alkyl;
pharmaceutically acceptable prodrug derivatives; and pharmaceutically acceptable salts thereof.

REFERENCES:
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4885027 (1989-12-01), Pomidor
patent: 4996358 (1991-02-01), Handa et al.
patent: 5114953 (1992-05-01), Galardy et al.
patent: 5137914 (1992-08-01), Ohtani et al.
patent: 5240958 (1993-08-01), Campion et al.
Chemical Abstracts, vol. 59, No. 3, Abstract 3824b, Aug. 5, 1963.
Trends Biotechnol., vol. 10, No. 6, 1992, pp. 200-207.
BioEssays, vol. 14, No. 7--Jul. 1992, pp. 455-463.
Annual Reports in Medicinal Chemistry, 25, pp. 177-184, 1989.
J. Med. Chem., 1989, 32, 145-151.
Synthesis, 1985, 929-931.
Chemical Abstract 93:81521r, 1980.
Chemical Abstract 59, 3824a (1963).
Microchemical Journal, 40, 226-232 (1989).
Chemical Abstract 70:88228j, 1959.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Arylsulfonamido-substituted hydroxamic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylsulfonamido-substituted hydroxamic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamido-substituted hydroxamic acids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1077697

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.